» Articles » PMID: 27796712

Female X-linked Alport Syndrome with Somatic Mosaicism

Abstract

Background: X-linked Alport syndrome (XLAS) is a progressive, hereditary nephropathy. Although males with XLAS usually develop end-stage renal disease before 30 years of age, some men show a milder phenotype and possess somatic mosaic variants of the type IV collagen α5 gene (COL4A5), with severity depending on variant frequencies. In females, somatic mosaic variants are rarely reported in XLAS, and it is not clear what determines severity.

Methods: Two females with somatic mosaic mutations in COL4A5 with variant frequencies of 17.9 and 22.1% were detected using the next-generation sequencing. One patient only had hematuria. The other, however, had moderate proteinuria, which is a severe phenotype for a female XLAS patient of her age. The molecular mechanisms for the severe phenotype were investigated by examining variant frequencies in urinary sediment cells and X chromosome inactivation patterns, and by looking for modifier variants in podocyte-related genes using the next-generation sequencing.

Results: The severe phenotype patient had a variant frequency of 36.6% in urinary sediment cells, which is not markedly high, nor did she show skewed X chromosome inactivation. However, she did have the heterozygous variant in COL4A3, which can affect severity.

Conclusion: Factors determining severity in female XLAS patients remain unclear. One studied patient with the somatic variant in COL4A5 showed a severe phenotype without skewed X chromosome inactivation, which might be derived from digenic variants in COL4A3 and COL4A5. Further studies are required to determine molecular mechanisms behind female XLAS resulting in the severe phenotype.

Citing Articles

Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese.

Lim T, Koh C, Savige J, Ng A, Ng J, Chin H Sci Rep. 2025; 15(1):7691.

PMID: 40044766 PMC: 11883019. DOI: 10.1038/s41598-025-92520-9.


Clinical, Pathological, and Genetic Characteristics of Patients with Digenic Alport Syndrome.

Inoki Y, Horinouchi T, Yamamura T, Ishimori S, Ichikawa Y, Tanaka Y Kidney360. 2024; 5(10):1510-1517.

PMID: 39137047 PMC: 11556934. DOI: 10.34067/KID.0000000000000547.


The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy-A human genetics department experience.

Comic J, Riedhammer K, Gunthner R, Schaaf C, Richthammer P, Simmendinger H Front Med (Lausanne). 2022; 9:957733.

PMID: 36117978 PMC: 9470833. DOI: 10.3389/fmed.2022.957733.


Detection of Very Low-Level Somatic Mosaic Splicing Variant in Asymptomatic Female Using Droplet Digital PCR.

Deng H, Zhang Y, Ding J, Wang F Front Med (Lausanne). 2022; 9:847056.

PMID: 35360741 PMC: 8963732. DOI: 10.3389/fmed.2022.847056.


The 2019 and 2021 International Workshops on Alport Syndrome.

Daga S, Ding J, Deltas C, Savige J, Lipska-Zietkiewicz B, Hoefele J Eur J Hum Genet. 2022; 30(5):507-516.

PMID: 35260866 PMC: 8904161. DOI: 10.1038/s41431-022-01075-0.


References
1.
Cheong H, Park H, Ha I, Choi Y . Mutational analysis of COL4A5 gene in Korean Alport syndrome. Pediatr Nephrol. 2000; 14(2):117-21. DOI: 10.1007/s004670050025. View

2.
Mencarelli M, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C . Evidence of digenic inheritance in Alport syndrome. J Med Genet. 2015; 52(3):163-74. DOI: 10.1136/jmedgenet-2014-102822. View

3.
Kashtan C, Ding J, Gregory M, Gross O, Heidet L, Knebelmann B . Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol. 2012; 28(1):5-11. PMC: 3505543. DOI: 10.1007/s00467-012-2138-4. View

4.
Kubota T, Nonoyama S, Tonoki H, Masuno M, Imaizumi K, Kojima M . A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR. Hum Genet. 1999; 104(1):49-55. DOI: 10.1007/s004390050909. View

5.
. Finishing the euchromatic sequence of the human genome. Nature. 2004; 431(7011):931-45. DOI: 10.1038/nature03001. View